We are thrilled to announce that CancerAppy has been selected to participate in the Spanish delegation of the 4YFN 2021 event.
CancerAppy is pleased to announce that some new applications are now available in their proprietary platform.
One of them is the GeneReport tool, a personalized treatment matched application, that permits score predicted treatments with patient genomic actionable information.
Oncologists and physicians involved in cancer care, can easily match genomic information from patients with therapeutic options given alone or in combination. GeneReport provides the full information that a healthcare provider need to know to offer the maximum quality care.
GeneReport can reduce time, increase accuracy and help to select the best therapeutic options from all FDA approved drugs independently of the type of cancer, based on the patient genomic information. It is a necessary tool for physician teams involved in the treatment decision-making process of cancer patients.
We cannot be more proud and happy with our team since Cancerappy has obtained the positive resolution of the Neotec 2020 program in this especially competitive year.
Cancerappy had the opportunity to present its project as it was one of the 24 startups selected to present in this year’s edition of B-Venture2020 that was held in October in Bilbao.
She’s a scientist who does research on medications that treat cancer. Now Sarah’s a busy woman, so she doesn’t have the 21 hours a day it would take to read and process all the new information that comes out about cancer everyday.
But luckily for Sarah, we’ve got a solution for that: CANCERAPPY.
Cancerappy analyzes, organizes, and synthesizes all the information a cancer researcher needs, providing a holistic vision and saving valuable time and resources.
Cancerappy works because we created our own algorithm using artificial intelligence and these are things it gives us:
-Health Care Solutions
-Best Personalized Treatment
-Optimal drug development
Cancerappy provides unique value through the precise metrics it offers through big data and artificial intelligence which helps oncology professionals like Sarah make better decisions, save time, and increase the quality of care for any cancer patient.